CN101679237A - 制备(r)-2-甲基吡咯烷和(s)-2-甲基吡咯烷及其酒石酸盐的方法 - Google Patents

制备(r)-2-甲基吡咯烷和(s)-2-甲基吡咯烷及其酒石酸盐的方法 Download PDF

Info

Publication number
CN101679237A
CN101679237A CN200880021225A CN200880021225A CN101679237A CN 101679237 A CN101679237 A CN 101679237A CN 200880021225 A CN200880021225 A CN 200880021225A CN 200880021225 A CN200880021225 A CN 200880021225A CN 101679237 A CN101679237 A CN 101679237A
Authority
CN
China
Prior art keywords
crassitude
tartrate
methyl
phenyl
tetramethyleneimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880021225A
Other languages
English (en)
Chinese (zh)
Inventor
迈克尔·克里斯蒂
约瑟夫·J·佩特雷蒂斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of CN101679237A publication Critical patent/CN101679237A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Cosmetics (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN200880021225A 2007-05-03 2008-05-02 制备(r)-2-甲基吡咯烷和(s)-2-甲基吡咯烷及其酒石酸盐的方法 Pending CN101679237A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (1)

Publication Number Publication Date
CN101679237A true CN101679237A (zh) 2010-03-24

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880021225A Pending CN101679237A (zh) 2007-05-03 2008-05-02 制备(r)-2-甲基吡咯烷和(s)-2-甲基吡咯烷及其酒石酸盐的方法

Country Status (14)

Country Link
EP (1) EP2152669A1 (es)
JP (1) JP5698887B2 (es)
KR (1) KR20100017565A (es)
CN (1) CN101679237A (es)
AU (1) AU2008248168B2 (es)
BR (1) BRPI0810330A2 (es)
CA (1) CA2686033A1 (es)
EA (1) EA019031B1 (es)
IL (1) IL201627A (es)
MX (1) MX2009011787A (es)
NZ (1) NZ580948A (es)
UA (1) UA99913C2 (es)
WO (1) WO2008137087A1 (es)
ZA (1) ZA200907643B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2397283T3 (es) 2006-07-25 2013-03-06 Cephalon, Inc. Derivados de piridizinona
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) * 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
EP3237408B1 (en) * 2014-12-23 2018-10-31 Cephalon, Inc. Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013838A2 (en) * 2006-07-25 2008-01-31 Cephalon, Inc. Pyridizinone derivatives

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
CN100543050C (zh) 2004-03-08 2009-09-23 独立行政法人科学技术振兴机构 高分子担载金属簇组合物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
ES2299074T3 (es) 2004-06-02 2008-05-16 F. Hoffmann-La Roche Ag Derivados de naftaleno utiles como ligandos del receptor 3 de la histamina.
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
JP2008524252A (ja) 2004-12-17 2008-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Cns障害の処置のためのテトラヒドロイソキノリン化合物
JP2008526895A (ja) 2005-01-21 2008-07-24 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なイミダゾールおよびベンゾイミダゾール誘導体
CA2602336A1 (en) 2005-03-31 2006-10-05 Ucb Pharma S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CA2627234A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
WO2007094962A2 (en) 2006-02-09 2007-08-23 Athersys, Inc. Pyrazoles for the treatment of obesity and other cns disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
US20090163482A1 (en) 2006-03-13 2009-06-25 Mchardy Stanton Furst Tetralines antagonists of the h-3 receptor
WO2008005338A1 (en) 2006-06-29 2008-01-10 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013838A2 (en) * 2006-07-25 2008-01-31 Cephalon, Inc. Pyridizinone derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LUCIA A. VAN DE KUILL 等: "Organonickel(II) complexes containing aryl ligands with chiral pyrrolidinyl ring systems; syntheses and use as homogeneous catalysts for the Kharasch addition reaction", 《RECUEIL DES TRAVAUX CHIMIQUES DES PAY-BAS》 *

Also Published As

Publication number Publication date
WO2008137087A1 (en) 2008-11-13
JP5698887B2 (ja) 2015-04-08
IL201627A0 (en) 2010-05-31
JP2010526142A (ja) 2010-07-29
AU2008248168A1 (en) 2008-11-13
AU2008248168B2 (en) 2013-03-21
BRPI0810330A2 (pt) 2014-10-14
NZ580948A (en) 2011-04-29
EA019031B1 (ru) 2013-12-30
ZA200907643B (en) 2014-03-26
EA200971019A1 (ru) 2010-04-30
CA2686033A1 (en) 2008-11-13
UA99913C2 (ru) 2012-10-25
IL201627A (en) 2014-06-30
KR20100017565A (ko) 2010-02-16
EP2152669A1 (en) 2010-02-17
MX2009011787A (es) 2009-11-13

Similar Documents

Publication Publication Date Title
US20100121055A1 (en) Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
ES2552503T3 (es) Derivado de piridina y pirazina para el tratamiento de fibrosis quística (CF)
ES2300837T3 (es) Compuestos triciclicos como inhibidores de transporte de glicina.
EP1991528A2 (en) Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
EP1680124B1 (en) Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
WO2003028728A1 (en) 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
JP2003505373A (ja) ビフェニル誘導体、その製法及び薬剤としての使用
EP0776327A1 (en) New multimerizing agents
US20120041205A1 (en) Preparation of dihydropyrrol derivatives as intermediates
CA2097517A1 (en) N-substituted lactams useful as cholecystokinin antagonists
MX2011003924A (es) Dusulfonamidas sustituidas como moduladores de bri.
CN101679237A (zh) 制备(r)-2-甲基吡咯烷和(s)-2-甲基吡咯烷及其酒石酸盐的方法
CN109563023A (zh) 制备取代联苯的方法
CN101391978B (zh) Hiv-1蛋白酶抑制剂阿扎那韦的合成方法
CN101284807B (zh) 盐酸坦索罗辛的制备方法
JPS61238784A (ja) コハク酸イミド誘導体及びその酸付加塩
WO2003028725A1 (en) 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands
RU2222535C2 (ru) 3-тетрагидропиридин-4-илиндолы для лечения психотических нарушений
JP5297386B2 (ja) 5−アルキルオキシ−インドリン−2−オン誘導体、これらの調製およびv2バソプレシン受容体の選択的リガンドとしての治療におけるこれらの応用
TW414791B (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
CA2364108A1 (en) Acylamino cyclopropane derivatives
AU2003253114A1 (en) Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
Vilums et al. WHEN STRUCTURE–AFFINITY RELATIONSHIPS MEET STRUCTURE–KINETICS RELATIONSHIPS: 3-((INDEN-1-YL) AMINO)-1-ISOPROPYL
CN117362234A (zh) 一种5-溴-7氯-1h吲唑的制备方法
JP2007161608A (ja) N−(ヘテロ)アリール置換含窒素ヘテロアリール化合物の製造方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100324